Alva Emily Peterson
- SEC CIK
- 0001738422
No open-market purchases or sales filed in the past year.
Current role at each company
- AMRX Amneal Pharmaceuticals, Inc.Directoras of May 8, 2025
- ALKS Alkermes plc.Directoras of Jul 1, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Alva Emily Peterson as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AMRX Amneal Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 (view filing) | Mar 5 | 2 days | Alva Emily PetersonDirector | SSaleClass A Common Stock | −80.0K | $8.90 | −$712.0K | −31.9%170.8K after |
ALKS Alkermes plc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2021 (view filing) | Aug 23 | 1 day | Alva Emily PetersonDirector | PPurchase | +1.65K | $30.22 | +$49.9K | New position1.65K after |